Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1985 1
1987 2
1988 2
1989 1
1991 2
1992 2
1993 12
1994 17
1995 3
1996 6
1997 4
1998 6
1999 4
2000 10
2001 2
2002 7
2003 8
2004 11
2005 9
2006 9
2007 10
2008 7
2009 18
2010 20
2011 19
2012 17
2013 20
2014 23
2015 19
2016 5
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

259 results
Results by year
Filters applied: . Clear all
Page 1
Intestinal mucosal barrier function in health and disease.
Turner JR. Turner JR. Nat Rev Immunol. 2009 Nov;9(11):799-809. doi: 10.1038/nri2653. Nat Rev Immunol. 2009. PMID: 19855405 Review.
Chemotherapy-induced peripheral neuropathy: Current status and progress.
Brewer JR, Morrison G, Dolan ME, Fleming GF. Brewer JR, et al. Gynecol Oncol. 2016 Jan;140(1):176-83. doi: 10.1016/j.ygyno.2015.11.011. Epub 2015 Nov 7. Gynecol Oncol. 2016. PMID: 26556766 Free PMC article. Review.
Prolonged Pharmacokinetic Interaction Between Capecitabine and a CYP2C9 Substrate, Celecoxib.
Ramírez J, House LK, Karrison TG, Janisch LA, Turcich M, Salgia R, Ratain MJ, Sharma MR. Ramírez J, et al. J Clin Pharmacol. 2019 Dec;59(12):1632-1640. doi: 10.1002/jcph.1476. Epub 2019 Jul 5. J Clin Pharmacol. 2019. PMID: 31274208 Clinical Trial.
Basic principles of tumor-associated regulatory T cell biology.
Savage PA, Malchow S, Leventhal DS. Savage PA, et al. Trends Immunol. 2013 Jan;34(1):33-40. doi: 10.1016/j.it.2012.08.005. Epub 2012 Sep 19. Trends Immunol. 2013. PMID: 22999714 Free PMC article. Review.
Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer.
Rose MC, Kostyanovskaya E, Huang RS. Rose MC, et al. Genomics Proteomics Bioinformatics. 2014 Oct;12(5):198-209. doi: 10.1016/j.gpb.2014.10.003. Epub 2014 Oct 28. Genomics Proteomics Bioinformatics. 2014. PMID: 25449594 Free PMC article. Review.
The evolving challenge of therapy-related myeloid neoplasms.
Churpek JE, Larson RA. Churpek JE, et al. Best Pract Res Clin Haematol. 2013 Dec;26(4):309-17. doi: 10.1016/j.beha.2013.09.001. Epub 2013 Oct 1. Best Pract Res Clin Haematol. 2013. PMID: 24507808 Free PMC article. Review.
Circulating microRNAs as biomarkers for inflammatory diseases.
Mi S, Zhang J, Zhang W, Huang RS. Mi S, et al. Microrna. 2013;2(1):63-71. doi: 10.2174/2211536611302010007. Microrna. 2013. PMID: 25019052 Free PMC article. Review.
The impact of the Cancer Genome Atlas on lung cancer.
Chang JT, Lee YM, Huang RS. Chang JT, et al. Transl Res. 2015 Dec;166(6):568-85. doi: 10.1016/j.trsl.2015.08.001. Epub 2015 Aug 10. Transl Res. 2015. PMID: 26318634 Free PMC article. Review.
Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond.
Delaney C, Frank S, Huang RS. Delaney C, et al. Chin J Cancer. 2015 Apr 8;34(4):149-60. doi: 10.1186/s40880-015-0007-9. Chin J Cancer. 2015. PMID: 25962919 Free PMC article. Review.
Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.
Weng L, Zhang L, Peng Y, Huang RS. Weng L, et al. Pharmacogenomics. 2013 Feb;14(3):315-24. doi: 10.2217/pgs.12.213. Pharmacogenomics. 2013. PMID: 23394393 Free PMC article. Review.
259 results
Jump to page
Feedback